Bausch Health Companies Inc.

URI: https://gptkb.org/entity/Bausch_Health_Companies_Inc.

GPTKB entity

Statements (72)

Predicate	Object
gptkbp:instanceOf	gptkb:public_company
gptkbp:CEO	gptkb:Thomas_J._Appio
gptkbp:chairman	gptkb:Joseph_C._Papa
gptkbp:countryOfOperation	gptkb:Canada gptkb:United_States International
gptkbp:CUSIP	071734107
gptkbp:formerName	gptkb:Valeant_Pharmaceuticals_International,_Inc.
gptkbp:founded	1959
gptkbp:headquartersLocation	gptkb:Laval,_Quebec,_Canada
https://www.w3.org/2000/01/rdf-schema#label	Bausch Health Companies Inc.
gptkbp:industry	Medical devices Pharmaceuticals
gptkbp:ISIN	CA0717341071
gptkbp:marketedBrands	gptkb:Addyi gptkb:Alaway gptkb:Besivance gptkb:Biotrue gptkb:Cuprimine gptkb:Elidel gptkb:Lotemax gptkb:Ocuvite gptkb:PreserVision gptkb:Prolensa gptkb:Retin-A_Micro gptkb:Syprine gptkb:Targretin gptkb:TheraTears gptkb:Wellbutrin_XL gptkb:Zyclara gptkb:Daliresp gptkb:Teflaro gptkb:Arestin gptkb:Lumify gptkb:Solta_Medical gptkb:Vyzulta gptkb:Xenazine gptkb:Bausch_+_Lomb gptkb:Jublia gptkb:Relistor gptkb:Salix_Pharmaceuticals gptkb:Xifaxan gptkb:Zovirax gptkb:Zyvox gptkb:Luzu gptkb:Glumetza gptkb:Sivextro gptkb:Aplenzin gptkb:Duac gptkb:Duobrii gptkb:Onexton gptkb:Trulance gptkb:Vimovo gptkb:Zylet gptkb:Zymaxid gptkb:Zytiga
gptkbp:netIncome	-$0.53 billion (2022)
gptkbp:notableEvent	Involved in major drug pricing controversy (2015-2016) Spun off Bausch + Lomb in 2022 Rebranded from Valeant Pharmaceuticals to Bausch Health in 2018
gptkbp:numberOfEmployees	~7,000 (2023)
gptkbp:products	Medical devices Pharmaceutical drugs Over-the-counter products
gptkbp:revenue	$8.12 billion (2022)
gptkbp:stockExchange	gptkb:New_York_Stock_Exchange gptkb:Toronto_Stock_Exchange
gptkbp:stockSymbol	gptkb:BHC
gptkbp:subsidiary	gptkb:Bausch_+_Lomb
gptkbp:website	https://www.bauschhealth.com/
gptkbp:bfsParent	gptkb:Valeant_Pharmaceuticals
gptkbp:bfsLayer	6